ET Awards: Groww CEO Lalit Keshre on building India’s largest stock broking platform and future growth plansGroww, led by Lalit Keshre, has become India's top stock broking platform. The company recently saw its market capitalization surge signifi...
ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwideCyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...
Poonawalla's clear shot at access for all via route socialCyrus S Poonawalla, chairman of Serum Institute of India, has created a legacy where business and social impact go hand in hand. His vaccin...
Funding for innovations key for India to remain vaccine leader: Cyrus PoonawallaSpeaking to ET after receiving the Lifetime Achievement Award for 2025 as part of the ET Awards for Corporate Excellence, Cyrus Poonawalla,...
Serum Institute joins CEPI network for vaccines against unknown pathogens (Disease X)Serum Institute of India (SII) has announced its partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) network, based...
SII's Poonawalla makes clarion call for global certification of vaccines"Multilateral organisations such as the United Nations and the World Trade Organisation should take it upon themselves to harmonise the cer...
Covovax approval to strengthen immunization efforts in India, lower and middle income countries, says SIIHe was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...
Fire at Serum Institute of India: Production of BCG, Rotavirus vaccines impactedApart from financial loss, the mishap will impact the production of BCG and Rotavirus vaccines, the company said in a statement.
Serum pegs losses due to fire at over Rs 1,000 crore; Maha CM says probe in blaze onThe chief minister visited the SII on Friday to take stock of the damages. He later addressed a press conference, where Adar Poonawalla, Ch...
Covishield dispatch for vaccine drive a historic moment: SIISerum Institute of India CEO Adar Poonawalla said the real challenge lies in taking the vaccine to the "common man, to the vulnerable group...
Serum Institute gets 'Covishield' purchase order from CentreThe SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this...
Bangladesh on track to receive Covid vaccines from IndiaThe PM has said that India will make vaccines for all humanity and that is a commitment at the highest level, highly placed sources told ET...
DCGI may await UK nod for AstraZeneca's Covid shot before approving SII vaccineOfficials said both the Pfizer and the SII emergency use applications are being reviewed on an accelerated basis. But as the trials for Ser...
Serum Institute-ICMR finish enrollment of participants for phase 3 trial of Covid-19 vaccineSII has already manufactured 40 million doses of the vaccine, under the at-risk manufacturing and stockpiling license from DCGI, the compan...
Bangladesh’s top pharma group & Serum Institute of India join hands for Covid-19 vaccineThe investment amount will be treated as an advance and once the vaccine receives regulatory approvals, SII will include Bangladesh among t...
Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and othersThe company, privately owned by Cyrus Poonawalla and his son Adar Poonawalla, plans to float a special purpose vehicle (SPV) for its vaccin...
Serum Institute of India acquires Czech Republic's NanotherapeuticsSII, Pune is currently one of the largest manufacturers of MMR group of vaccines and Pentavalent group of vaccines in the world, present in...